BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile

 

Chiasma Inc. 

10 Hartom Street, 2nd Floor
P.O. Box 45182
Jerusalem    91450  Israel
Phone: 972-2-571-5885 Fax: 972-2-571-5886


SEARCH JOBS










 Company News
Roche (RHHBY) Backs Out Of $600 Million Acromegaly Drug Development Deal With Chiasma Inc. 8/13/2014 5:55:26 AM
Roche (RHHBY) and Chiasma Inc. to Ally on Drug Development for Up to $600 Million 2/19/2013 6:58:50 AM
Chiasma Inc. Closes $38.5 Million Equity Financing 7/23/2012 10:20:16 AM
Chiasma Inc. Release: Data on Investigational Oral Octreolin™ for Acromegaly Demonstrate Growth Hormone Suppression 6/27/2012 9:31:44 AM
Chiasma Inc. to Present at the UBS Global Life Sciences Conference 9/14/2011 10:54:14 AM
Chiasma Inc.'s Octreolin(TM) (Oral Octreotide) Shown to Inhibit Growth Hormone in Healthy Subjects 6/6/2011 11:41:29 AM
Chiasma Inc. to Present at the UBS Global Life Sciences Conference 9/21/2010 8:31:44 AM
Chiasma (Israel) Ltd. Receives Orphan Drug Designation From the FDA for Octreolin(TM) for the Oral Treatment of Acromegaly 6/28/2010 9:01:15 AM
Chiasma Secures $11 Million 1/12/2009 8:54:46 AM
Chiasma Raises $44 Million Series C To Fund Clinical Testing, Advance Technology 11/15/2006 9:42:22 AM
12